Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suramin + Carboplatin + Paclitaxel in NSCLC
NCT00006929Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Sep 2000
- Primary completion
- Nov 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of suramin in non-small cell lung cancer (NSCLC), sponsored by National Cancer Institute. Started Sep 2000; status: completed.
02
Drugs
suramin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00006929.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006929.